Our Story

Our Story

BiFlow was founded in early 2011 and has continuously developed its technology platform to make it a versatile tool for the integration of novel assays or biosensors.

2023

Launch of BiFlow's Universal Cartridge Reader UCAR. It can control all functions of BiFlow's cartridges and read and analyze their fluorescence microarrays. Together with specially developed cartridges it forms our 30minLAB.

Learn more

2022

Introduction of our novel, even more versatile Evaluation Kit v6.

Learn more

2021

After 10 years of bootstrapping the company, BiFlow performed a strategic re-focussing and decided to move away from bootstrapped growth in the future. This will allow BiFlow to even better meet its customers needs and address novel markets more quickly.

BiFlow has expanded its production capacity with new investments and an enlarged production area to now 250 m².

2020

Introduction of our amp.flow cartridge, capable of performing isothermal DNA amplification and hybridization on a microarray. Early functional prototype of our universal cartridge reader UCAR.

Learn more

2019

Introduction of our Evaluation Kit v5.

Learn more

2017

Introduction of our onsite.flow cartridge, for the first time providing normally-closed valves for reagent storage.

Further expansion of OEM production of cartridges for immunoassays, including customized cartridge designs.

2014

Introduction of a novel version of our first cartridge type "flex.flow" including a new, scalable technology for our substrates which create the pumping functionality. This new technology allows for increased shelf life of the cartridges.

Start of OEM production of immunoassay cartridges.

2012

Introduction of our first product, the Evaluation Kit v4 together with our first, versatile cartridge "flex.flow". This Evaluation Kit and cartridge allows for the first time new customers to get familar with the technology platform in a very short time.

2011

BiFlow Systems GmbH was founded in January and prepared for a bootstrapped growth. The company was built on 6 years of research and development of the founders in microfluidics and biochemistry.

Share by: